Virginia to resume use of Johnson & Johnson COVID-19 vaccine

RICHMOND, Va. (AP) — Virginia health officials have told providers to immediately resume their use of the Johnson & Johnson COVID-19 vaccine after federal agencies lifted a pause on the vaccine.

The decision came after the Centers for Disease Control and Prevention and the Food and Drug Administration found the benefits of the one-shot vaccine outweigh its risks.

Earlier this month, the agencies announced an investigation into six cases of an extremely rare blood clot disorder in recipients. One woman who died was a 45-year-old Virginia resident who received the vaccine on March 6. No link has been found and CDC data shows about seven million people in the U.S. have received a dose.

The Richmond Times-Dispatch reports that prior to the pause, Virginia had administered 184,000 J&J shots.

The chances of getting blood clots while infected with COVID-19 is roughly 20% , which is significantly higher than the risk posed by the vaccine.

“This extra scrutiny should instill confidence in the system that is in place to guarantee COVID-19 vaccine safety,” Dr. Danny Avula, the state’s vaccine coordinator, said in a statement Friday. “As with any vaccine, we encourage individuals to educate themselves on any potential side effects and to weigh that against the possibility of hospitalization or death from COVID-19.”

Avula received a J&J vaccine on April 1.

The post Virginia to resume use of Johnson & Johnson COVID-19 vaccine first appeared on News/Talk 960-AM & FM-107.3 WFIR.

Just Played

Text STOP to 52353 to opt-out

If you need assistance reviewing any of the information in our FCC Public File please contact our business office at 540.774.9200 or use the form on the contact us page of this site.